Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Top Analyst Upgrades and Downgrades: AMD, Applied Materials, Carnival, Dell, Karuna Therapeutics, Lowe’s, Noble Energy, PayPal, Square, Target, Virgin Galactic and More

Posted: November 21, 2019 at 9:05 am
Last updated: January 6, 2020 1:01 am

Stocks hit new highs earlier in the week, but more caution about a trade deal has added some uncertainty to the markets. Stocks were mixed on Thursday after having been ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, J&J, Replimune, Schlumberger, Transocean and More

Posted: November 20, 2019 at 8:55 am
Last updated: January 6, 2020 1:04 am

Markets have hit new highs recently, but the main indexes were all marginally lower on Wednesday morning. With the Dow Jones industrials up over 28,000 and the S&P 500 over ...
Read Full Story »

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Posted: April 8, 2019 at 11:10 am
Last updated: January 6, 2020 5:36 am

Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) have announced a collaboration to discover, develop and commercialize new RNA interference (RNAi) therapeutics for a broad range of ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Akamai, Dollar Tree, Hasbro, Intel, Mylan, Netflix, Papa John’s and More

Posted: August 13, 2018 at 8:45 am
Last updated: January 11, 2020 7:30 pm

The futures seesawed somewhat Monday morning as investors continued to keep a wary eye on some global hot spots, not the least of which is the ongoing situation in Turkey. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts, Zillow and More

Posted: August 7, 2018 at 9:00 am
Last updated: January 11, 2020 7:48 pm

Stocks were indicated to higher on Tuesday after Monday's recovery rally. Investors have seen a very strong earnings season, with 80% of the S&P 500 reporting earnings and over 70% ...
Read Full Story »

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Posted: March 31, 2018 at 8:40 am
Last updated: January 12, 2020 1:53 am

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Accenture, Amex, Cognizant, FireEye, Mastercard, PayPal, Verizon, Visa and More

Posted: March 28, 2018 at 9:00 am
Last updated: January 12, 2020 1:59 am

Stocks tried to continue Monday's gains on Tuesday, but the market failed to hold its rally with a big late-day sell-off. The major indices were set to open higher on ...
Read Full Story »

Even More Biopharma Catalysts Coming Through the End of March

Posted: March 17, 2018 at 7:55 am
Last updated: January 12, 2020 2:20 am

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Top 10 Biopharma Events Kicking Off 2018

Posted: December 28, 2017 at 11:50 am
Last updated: January 12, 2020 5:02 am

Biotechnology and pharmaceutical companies generally face a fair-to-great amount of risk based on the lengthy vetting process for their drug candidates, should a study come back negative or should a ...
Read Full Story »

50 Mid-Cap and Larger Stocks More Than Doubled in 2017

Posted: December 18, 2017 at 11:50 am
Last updated: January 12, 2020 5:21 am

With 2017 nearing an end, it is important to consider just what has happened. Tax reform looks very likely now, and gross domestic product is higher in the United States ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More

Posted: October 30, 2017 at 9:05 am

Stocks were indicated to open lower on Monday after hitting all-time highs last week. With the bull market now nearing nine years old, the one trend that has prevailed for ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

Posted: October 2, 2017 at 9:05 am

Stocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one trend that has been proven time after time in this eight-year bull market ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Axovant, Carnival, Micron, Nike, SunPower, Vivint Solar, Walgreens and More

Posted: September 27, 2017 at 8:50 am
Last updated: January 12, 2020 7:46 am

Stocks have sold off in recent days, with a four-day losing streak for the Dow Jones Industrial Averages. Wednesday was showing some strength after the president's tax plan is being shown ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron, Albermarle, Alnylam and More

Posted: September 21, 2017 at 9:05 am
Last updated: January 12, 2020 7:57 am

Stocks were indicated to open marginally lower on Thursday. This is on the heels of Wednesday's confirmation by Janet Yellen that the Federal Reserve would start selling down its $4.5 ...
Read Full Story »

Why Alnylam Pharmaceuticals Is Wednesday’s Top Stock

Posted: September 20, 2017 at 1:30 pm
Last updated: January 12, 2020 7:59 am

Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) saw its shares make a handy gain on Wednesday after the firm gave an update on its late-stage trial in patients with hereditary ATTR amyloidosis ...
Read Full Story »